APA (7th ed.) Citation

MVD, S., VE, G., RI, A., PNG, P., TC, V., L, M., . . . JF, L. (2026). Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease. Blood advances, 10(9), 2904. https://doi.org/10.1182/bloodadvances.2025017996

Chicago Style (17th ed.) Citation

MVD, Soares, et al. "Phase 1/2 Trials of Donor Regulatory T Cells for the Treatment of Steroid-refractory Chronic Graft-versus-host Disease." Blood Advances 10, no. 9 (2026): 2904. https://doi.org/10.1182/bloodadvances.2025017996.

MLA (9th ed.) Citation

MVD, Soares, et al. "Phase 1/2 Trials of Donor Regulatory T Cells for the Treatment of Steroid-refractory Chronic Graft-versus-host Disease." Blood Advances, vol. 10, no. 9, 2026, p. 2904, https://doi.org/10.1182/bloodadvances.2025017996.